Cite

HARVARD Citation

    Yang, Y. et al. (n.d.). A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV‐related HCC treated with sorafenib. Liver international. pp. 2147-2154. [Online]. 
  
Back to record